• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型定量受体功能模型SABRE在拟合具有挑战性的浓度-效应数据时的灵活性。

The flexibility of SABRE, a new quantitative receptor function model, when fitting challenging concentration-effect data.

作者信息

Olah Barbara, Tarjanyi Vera, Takacs Barbara, Pluzsnyik Edua, Viczjan Gabor, Ovari Ignac, Szilvassy Zoltan, Juhasz Bela, Zsuga Judit, Erdei Tamas, Gesztelyi Rudolf

机构信息

Department of Orthodontics, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary.

University of Debrecen, Doctoral School of Nutrition and Food Sciences, Debrecen, Hungary.

出版信息

Front Pharmacol. 2025 Jun 12;16:1591761. doi: 10.3389/fphar.2025.1591761. eCollection 2025.

DOI:10.3389/fphar.2025.1591761
PMID:40575783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12198161/
Abstract

The Signal Amplification, Binding affinity, and Receptor-activation Efficacy (SABRE) model is the most recent general and quantitative model of receptor function, which enables the determination of K (the equilibrium dissociation constant of the agonist-receptor complex) and q (the fraction of the operable receptors after a partial irreversible receptor inactivation) from purely functional data. The practical aim of the present study was to test the capabilities of this new model using concentration-effect (E/c) data from a previous investigation conducted in our laboratory. We have found that the SABRE model is at least as useful as two widely accepted older methods thought to have similar capabilities, the operational model of agonism and Furchgott's method, even if the quality of the data to be evaluated is somewhat challenging. Nevertheless, the SABRE model seems to require a large amount of high-quality and, regarding the experimental design, diverse data. In addition, it is important to find the most suitable fitting strategy for the particular sort of data in order to obtain reliable results. However, owing to its unique feature of distinguishing between receptor activation and activation of postreceptorial signaling, the SABRE model appears to be superior to previous quantitative receptor function models in simulating E/c curves and thereby clarifying, explaining or simply illustrating theoretical issues.

摘要

信号放大、结合亲和力和受体激活效能(SABRE)模型是受体功能领域最新的通用定量模型,它能够仅从功能数据确定K(激动剂 - 受体复合物的平衡解离常数)和q(部分不可逆受体失活后可操作受体的比例)。本研究的实际目的是利用我们实验室之前一项研究中的浓度 - 效应(E/c)数据来测试这个新模型的能力。我们发现,即使待评估数据的质量颇具挑战性,SABRE模型至少与另外两种被广泛接受且被认为具有类似能力的旧方法——激动作用的操作模型和弗奇戈特方法——同样有用。然而,SABRE模型似乎需要大量高质量且在实验设计方面多样化的数据。此外,为了获得可靠的结果,找到最适合特定类型数据的拟合策略很重要。不过,由于其在区分受体激活和受体后信号激活方面的独特特性,SABRE模型在模拟E/c曲线以及由此阐明、解释或简单说明理论问题方面似乎优于先前的定量受体功能模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/f3261ba874d7/fphar-16-1591761-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/08c501006849/fphar-16-1591761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/f2daf423d804/fphar-16-1591761-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/f3261ba874d7/fphar-16-1591761-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/08c501006849/fphar-16-1591761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/f2daf423d804/fphar-16-1591761-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b50d/12198161/f3261ba874d7/fphar-16-1591761-g003.jpg

相似文献

1
The flexibility of SABRE, a new quantitative receptor function model, when fitting challenging concentration-effect data.新型定量受体功能模型SABRE在拟合具有挑战性的浓度-效应数据时的灵活性。
Front Pharmacol. 2025 Jun 12;16:1591761. doi: 10.3389/fphar.2025.1591761. eCollection 2025.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

本文引用的文献

1
Quantification of signal amplification for receptors: the /EC ratio of full agonists as a gain parameter.受体信号放大的定量分析:以完全激动剂的/EC比值作为增益参数。
Front Pharmacol. 2025 Apr 8;16:1541872. doi: 10.3389/fphar.2025.1541872. eCollection 2025.
2
Simple methods to determine the dissociation constant, K.简单方法测定离解常数 K。
Mol Cells. 2024 Oct;47(10):100112. doi: 10.1016/j.mocell.2024.100112. Epub 2024 Sep 16.
3
Quantitative receptor model for responses that are left- or right-shifted versus occupancy (are more or less concentration sensitive): the SABRE approach.
针对左移或右移反应与占有率(浓度敏感性或多或少)的定量受体模型:SABRE方法。
Front Pharmacol. 2023 Dec 15;14:1274065. doi: 10.3389/fphar.2023.1274065. eCollection 2023.
4
Quantification of receptor binding from response data obtained at different receptor levels: a simple individual sigmoid fitting and a unified SABRE approach.从不同受体水平获得的反应数据中定量受体结合:一种简单的个体 S 型拟合和一种统一的 SABRE 方法。
Sci Rep. 2022 Nov 6;12(1):18833. doi: 10.1038/s41598-022-23588-w.
5
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A Adenosine Receptor Antagonist So Far.迄今为止,FSCPX 被认为是一种选择性不可逆 A 腺苷受体拮抗剂,有大量间接证据表明其具有不可逆的外核苷酸酶抑制作用。
Int J Mol Sci. 2021 Sep 11;22(18):9831. doi: 10.3390/ijms22189831.
6
A single unified model for fitting simple to complex receptor response data.用于拟合简单到复杂受体反应数据的单一统一模型。
Sci Rep. 2020 Aug 7;10(1):13386. doi: 10.1038/s41598-020-70220-w.
7
100 years of modelling ligand-receptor binding and response: A focus on GPCRs.100年的配体-受体结合与反应建模:聚焦于G蛋白偶联受体
Br J Pharmacol. 2020 Apr;177(7):1472-1484. doi: 10.1111/bph.14988. Epub 2020 Feb 28.
8
Quantitative structural assessment of graded receptor agonism.定量结构评估分级受体激动剂。
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22179-22188. doi: 10.1073/pnas.1909016116. Epub 2019 Oct 14.
9
Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.激动剂、拮抗剂和 A1 腺苷受体变构调节剂的药物化学和治疗潜力:现状和展望。
Curr Pharm Des. 2019;25(25):2697-2715. doi: 10.2174/1381612825666190716100509.
10
A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data.一种针对复杂分数反应与占有率数据的具有结合亲和力、激活效力和信号放大参数的受体模型。
Front Pharmacol. 2019 Jun 11;10:605. doi: 10.3389/fphar.2019.00605. eCollection 2019.